Zusammenfassung
HIV-Patienten leiden an einer großen Zahl infektiöser und nichtinfektiöser Haut- und Schleimhauterkrankungen, einige davon besitzen Markerfunktion für ein schwächer werdendes Immunsystem. Obwohl keine der dermatologischen Komplikationen pathognomonische Bedeutung besitzt, müssen z. B. die orale Haarleukoplakie, der Herpes zoster, die orale Kandidose bzw. die eosinophile Follikulitis Ofuji bei entsprechenden Patienten an eine HIV-Infektion denken lassen. Der Verdacht auf HIV besteht auch, wenn eine der aufgeführten Dermatosen atypisch oder besonders schwer verläuft bzw. schlecht auf eine geeignete Therapie anspricht. Die wesentlichsten häufigen und seltenen Dermatosen werden diskutiert.
Abstract
HIV patients develop a variety of infectious and non-infectious diseases of the skin and mucous membranes. Some of these serve as indicator diseases for a weakening immune system. While none of the dermatological complications is pathognomonic, conditions such as oral hairy leukoplakia, herpes zoster, thrush, and eosinophilic folliculitis should make physicians consider the possibility of underlying HIV disease. Moreover, one has to consider HIV if these skin diseases take an atypical or severe course, or if they do not respond properly to appropriate medication. Frequent and rare dermatoses occurring in HIV infection are discussed.
Literatur
Amerio P, Verdolini R, Proietto G et al. (2001) Role of Th2 cytokines, RANTES, and eotaxin in AIDS associated eosinophilic folliculitis. Acta Derm Venereol 81: 92–95
Bachelez H, Hadida F, Gorochov G (1996) Massive infiltration of the skin by HIV-specific cytotoxic CD8+ T cells. N Engl J Med 335: 61–62
Bär A, Hantschke D, Mirmohammadsadegh A, Hengge UR (2003) Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections (SSTI): emergence of methicillin-resistant Staphylococci. AIDS 17: 1253–1256
Barbagallo J, Tager P, Ingleton R et al. (2002) Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 3: 319–328
Brown DR, Schroeder JM, Bryan JT et al. (1999) Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37: 3316–3322
Chiao EY, Krown SE, Stier EA, Schrag D (2005) A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 40: 451–455
Chin-Hong PV, Palefsky JM (2002) Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 35: 1127–1134
Clifford GM, Polesel J, Rickenbach M et al. (2005) Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425–432
Ellis E, Scheinfeld N (2004) Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol 5: 189–197
Engels EA, Frisch M, Goedert JJ et al. (2002) Merkel cell carcinoma and HIV infection. Lancet 359: 497–498
Fidel PL Jr (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 19: 80–84
Foucault C, Brouqui P, Raoult D (2006) Bartonella quintana characteristics and clinical management. Emerg Infect Dis 12: 217–223
Franceschi S, Dal Maso L, Arniani S et al. (1998) Risk of cancer other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 78: 966–970
Franceschi S, Bidoli E, Herrero R, Munoz N (2000) Comparison of cancers of the oral cavity and pharynx worlwide: etiological clues. Oral Oncol 36: 106–115
Frisch M, Glimelius B, Van den Brule AJ et al. (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337: 1350–1358
Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92: 1500–1510
Gibbs S, Harvey I, Sterling JC, Stark R (2001, 2003) Local treatments for cutaneous warts. Cochrane Database Syst Rev 3: CD001781
Gnann JW Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis [Suppl 1] 186: S91–S98
Goedert JJ, Cote TR, Virgo P et al. (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833–1899
Goldie SJ, Kuntz KM, Weinstein MC et al. (1999) The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281: 1822–1829
Gross G (2004) Herpes simplex virus infections. Hautarzt 55: 818–830
Guitart J, Variakojis D, Kuzel T, Rosen S (1999) Cutaneous CD8 T cell infiltrates in advanced HIV infection. J Am Acad Dermatol 41: 722–727
Gupta AK, Bluhm R (2004) Seborrheic dermatitis. J Eur Acad Dermatol Venereol 18: 13–26
Gupta AK, Taborda P, Taborda V et al. (2000) Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 39: 746–753
Handa S, Bingham J (2001) Dermatological immune restauration syndrome: does it exist? J Eur Acad Dermatol Venereol 15: 430–435
Hengge UR (1999) Die oropharyngeale Candidose. In: Jäger (Hrsg) Mit AIDS leben – Prävention, Therapie Behandlungsalternativen, psychosoziale Aspekte 1999. Ecomed, Landsberg, S 100–102
Hengge UR (2003) HPV-Infektion in der Dermastologie: Besonderheiten bei Organtransplantierten und HIV-Patienten. In: Hengge UR (Hrsg) HPV-Infektion und Neoplasien der Haut. Unimed, Bremen, S 50–60
Hengge UR (Hrsg) (2003) HPV-Infektion und Neoplasien der Haut. Unimed, Bremen
Hengge UR (2004) Papillomavirus diseases. Hautarzt 55: 841–854
Hengge U, Ruzicka T (Hrsg) (2006) Lehrbuch der Dermatologie und Venerologie. Ihr roter Faden durchs Studium nach der neuen ÄAppO. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Hengge UR, Tietze M (2000) Successful treatment of recalcitrant condyloma with topical cidofovi. Sex Transm Inf 76: 143
Hengge UR, Brockmeyer NH, Baumann M et al. (1993) Liposomal doxorubicin treatment of AIDS-related Kaposi’s sarcoma. Lancet 342: 497
Hengge UR, Esser S, Schultewolter T et al. (2000) Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 143: 1026–1031
Hengge UR, Franz B, Goos M (2000) Decline of infectious skin manifestations in the era of highly active antiretroviral therapy. AIDS 14: 1069–1070
Hengge UR, Ruzicka T, Tyring S et al. (2002) Update on Kaposi’s sarcoma and other HHV-8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2: 281–292
Hengge UR, Currie B, Jäger G et al. (in press) Scabies – an ubiquitous neglected skin disease. Lancet Infect Dis in press
Ikediobi NI, Tyring SK (2002) Cutaneous manifestations of Epstein-Barr virus infection. Dermatol Clin 20: 283–289
International Collaboration on HIV and Cancer (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92: 1823–1830
Kaspari M, Gutzmer R, Kaspari T et al. (2002) Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma. Br J Dermatol 147: 757–759
Koutsky LA, Ault KA, Wheeler CM et al. (2002) Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651
Liautaud B, Pape JW, DeHovitz JA (1989) Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 125: 629–632
Lilie HM, Wassilew SW (2004) Varicella-zoster virus infections. Hautarzt 55: 831–840
Mallon E, Bunker CB (2000) HIV-associated psoriasis. AIDS Patient Care STDS 14: 239–246
Maurer T, Rodrigues LK, Ameli N et al. (2004) The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis 38: 579–584
Murakawa GJ, Kerschmann R, Berger T (1996) Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Dermatol 132: 545–548
Nervi SJ, Schwartz RA, Dmochowski M (2006) Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol 55: 285–289
Nikkels AF, Snoeck R, Rentier B, Pierard GE (1999) Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects. Clin Exp Dermatol 24: 346–353
Palefsky JM, Holly EA, Ralston ML, Jay N (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177: 361–367
Palefsky JM, Holly EA, Ralston ML et al. (2001) Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 28: 422–428
Palefsky JM, Holly EA, Efirdc JT et al. (2005) Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19: 1407–1414
Peng Z, Simons FE (2004) Mosquito allergy: immunmechanisms and recombinant salivary allergens. Int Arch Allergy Immunol 133: 198–209
Resneck JS Jr, Van Beek M, Furmanski L et al. (2004) Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 292: 2614–2621
Rinne D, Linhart C, Schofer H (2000) Lip papillomatosis in immunodeficiency: therapy with imiquimod. Br J Dermatol 142: 196–197
Rodrigues LK, Klencke BJ, Vin-Christian K et al. (2002) Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol 138: 765–770
Saiag P, Bourgault-Villada I, Pavlovic M, Roudier-Pujol C (2002) Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy. AIDS 16: 1438–1440
Schwartz RA, Janusz CA, Janninger CK (2006) Seborrheic dermatitis: an overview. Am Fam Physician 74: 125–130
Singh F, Rudikoff D (2003) HIV-associated pruritus: etiology and management. Am J Clin Dermatol 4: 177–88
Smith KJ, Skelton H (2002) Molluscum contagiosum: recent advances in pathogenic mechanisms, and new therapies. Am J Clin Dermatol 3: 535–545
Sobhani I, Vuagnat A, Walker F et al. (2001) Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 125: 857–866
Stone K, Becker T, Hadgu A, Kraus S (1990) Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation. Genitourin Med 66: 16–19
Subramanian S, Mathai D (2005) Clinical manifestations and management of cryptococcal infection. J Postgrad Med 51: S21–26
Syrjänen K, Syrjänen S (2003) HPV bei Erkrankungen der Mundhöhle. In: Hengge UR (Hrsg) HPV-Infektion und Neoplasien der Haut. Unimed, Bremen, S 130–140
Tollesson A, Fritz A, Berg A, Karlman G (1993) Essential fatty acids in infantile seborrheic dermatitis. J Am Acad Dermatol 28: 957–961
Wilkins K, Turner R, Dolev JC et al. (2006) Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol 54: 189–206
Zancanaro PC, McGirt LY, Mamelak AJ et al. (2006) Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. J Am Acad Dermatol 54: 581–588
Zhang P, Chiriboga L, Jacobson M et al. (1995) Mycosis fungoides like T-cell cutaneous lymphoid infiltrates in patients with HIV infection. Am J Dermatopathol 17: 29–35
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hengge, U.R., Mota, R. & Marini, A. Häufige und seltene dermatologische Erkrankungen bei HIV-Patienten. Hautarzt 57, 975–987 (2006). https://doi.org/10.1007/s00105-006-1239-z
Issue Date:
DOI: https://doi.org/10.1007/s00105-006-1239-z